Search Results

There are 6445 results for: content related to: Chemotherapy of Advanced Colorectal Cancer

  1. Cancer of the Colon and Rectum

    Gastrointestinal Oncology: A Critical Multidisciplinary Team Approach

    Rachel S. Midgley, Omar Khan, Andrew Weaver, Daniel Royston, Bryan Warren, Margaret Betts, Baljit Singh, Chris Cunningham, Ami Sabharwal, David Kerr, Robert Glynne-Jones, Zahir Soonwalla, Fergus Gleeson, Carlos Escriu, Mark Middleton, Ann MacArthur, Julia Liddi, Pages: 325–373, 2009

    Published Online : 14 JAN 2009, DOI: 10.1002/9781444300147.ch14

  2. Systemic Treatment of Hepatobiliary Tumors

    Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

    Panagiotis Samaras, Michael A. Morse, Bernhard C. Pestalozzi, Pages: 107–121, 2009

    Published Online : 9 DEC 2009, DOI: 10.1002/9781444317053.ch10

  3. Epidermal Growth Factor Receptor Monoclonal Antibodies for the Treatment of Metastatic Colorectal Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 6, June 2008, Pages: 742–754, Gary W. Jean and Sachin R. Shah

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.6.742

  4. Evidence-based update of chemotherapy options for metastatic colorectal cancer

    ANZ Journal of Surgery

    Volume 74, Issue 9, September 2004, Pages: 781–787, Dragan Damjanovic, Paul Thompson and Michael P. N. Findlay

    Version of Record online : 20 SEP 2004, DOI: 10.1111/j.1445-1433.2004.03148.x

  5. Current Challenges in the Adjuvant Therapy of Colon Cancer

    Challenges in Colorectal Cancer

    George P. Kim, Axel Grothey, Pages: 133–152, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753231.ch9

  6. Future Directions in the Oncological Treatment of Colorectal Cancer

    Challenges in Colorectal Cancer

    Anthony El-Khoueiry, Heinz-Josef Lenz, Pages: 251–270, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753231.ch16

  7. You have free access to this content
    Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients

    Cancer

    Volume 118, Issue 12, 15 June 2012, Pages: 3173–3181, C. Daniel Mullins, Fei-Yuan Hsiao, Eberechukwu Onukwugha, Naimish B. Pandya and Nader Hanna

    Version of Record online : 21 OCT 2011, DOI: 10.1002/cncr.26613

  8. You have free access to this content
    Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statement

    HPB

    Volume 15, Issue 2, February 2013, Pages: 106–115, Roderich E. Schwarz, Jordan D. Berlin, Heinz J. Lenz, Bernard Nordlinger, Laura Rubbia-Brandt and Michael A. Choti

    Version of Record online : 24 SEP 2012, DOI: 10.1111/j.1477-2574.2012.00558.x

  9. Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases

    Journal of Surgical Oncology

    Volume 102, Issue 8, 15 December 2010, Pages: 946–954, Janine M. Davies and Richard M. Goldberg

    Version of Record online : 16 DEC 2010, DOI: 10.1002/jso.21653

  10. Clinical Use of Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 11P2, November 2008, Pages: 31S–41S, Dina K. Patel

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.11-supp.31S

  11. Anti-EGFR Monoclonal Antibodies for Treatment of Colorectal Cancers: Development of Cetuximab and Panitumumab

    The Journal of Clinical Pharmacology

    Volume 52, Issue 2, February 2012, Pages: 128–155, Dr Benoit You and Dr Eric X. Chen

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010395940

  12. You have full text access to this OnlineOpen article
    A systematic review of treatment guidelines for metastatic colorectal cancer

    Colorectal Disease

    Volume 14, Issue 2, February 2012, Pages: e31–e47, M. S. Edwards, S. D. Chadda, Z. Zhao, B. L. Barber and D. P. Sykes

    Version of Record online : 10 JAN 2012, DOI: 10.1111/j.1463-1318.2011.02765.x

  13. Biologic modulation of chemotherapy in patients with hepatic colorectal metastases: The role of anti-VEGF and anti-EGFR antibodies

    Journal of Surgical Oncology

    Volume 102, Issue 8, 15 December 2010, Pages: 937–945, Ravit Geva, Hans Prenen, Baki Topal, Raymond Aerts, Jaarke Vannoote and Eric Van Cutsem

    Version of Record online : 16 DEC 2010, DOI: 10.1002/jso.21760

  14. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases

    Journal of Surgical Oncology

    Volume 102, Issue 8, 15 December 2010, Pages: 988–995, T. Peter Kingham, Michael D'Angelica and Nancy E. Kemeny

    Version of Record online : 16 DEC 2010, DOI: 10.1002/jso.21753

  15. A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors

    Pediatric Blood & Cancer

    Volume 60, Issue 2, February 2013, Pages: 230–236, Margaret E. Macy, Tracey Duncan, James Whitlock, Stephen P. Hunger, Jessica Boklan, Aru Narendran, Cynthia Herzog, Robert J. Arceci, Rochelle Bagatell, Tanya Trippett, Uwe Christians, Katherine Rolla, S. Percy Ivy, Lia Gore and on behalf of the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC)

    Version of Record online : 28 SEP 2012, DOI: 10.1002/pbc.24278

  16. Clinical application of oxaliplatin in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1717–1732, S. FU, J.J. KAVANAGH, W. HU and R.C. BAST Jr

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00654.x

  17. Retrospective analysis on the efficacy of bevacizumab with FOLFOX as a first-line treatment in Japanese patients with metastatic colorectal cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 4, December 2014, Pages: 322–329, Mitsukuni Suenaga, Nobuyuki Mizunuma, Satoshi Matsusaka, Eiji Shinozaki, Masashi Ueno and Toshiharu Yamaguchi

    Version of Record online : 5 AUG 2013, DOI: 10.1111/ajco.12094

  18. You have full text access to this OnlineOpen article
    Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer

    Cancer Medicine

    Volume 4, Issue 10, October 2015, Pages: 1505–1513, Shouki Bazarbashi, Ali Aljubran, Ahmad Alzahrani, Ahmed Mohieldin, Hussein Soudy and Mohammed Shoukri

    Version of Record online : 24 JUL 2015, DOI: 10.1002/cam4.497

  19. You have free access to this content
    Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults

    Cancer

    Volume 118, Issue 11, 1 June 2012, Pages: 2925–2934, Christina D. Mack, William Carpenter, Anne-Marie Meyer, Hanna Sanoff and Til Stürmer

    Version of Record online : 9 NOV 2011, DOI: 10.1002/cncr.26622

  20. You have free access to this content
    Incidence and relative risk of grade 3 and 4 diarrhoea in patients treated with capecitabine or 5-fluorouracil: a meta-analysis of published trials

    British Journal of Clinical Pharmacology

    Volume 78, Issue 6, December 2014, Pages: 1228–1237, Roberto Iacovelli, Filippo Pietrantonio, Antonella Palazzo, Claudia Maggi, Francesca Ricchini, Filippo de Braud and Maria Di Bartolomeo

    Version of Record online : 20 NOV 2014, DOI: 10.1111/bcp.12449